These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 19121181

  • 1. A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection.
    Satoh K, Iwata-Takakura A, Yoshikawa A, Gotanda Y, Tanaka T, Yamaguchi T, Mizoguchi H.
    Vox Sang; 2008 Oct; 95(3):174-80. PubMed ID: 19121181
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 4. Occult hepatitis B virus infection.
    Allain JP.
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [Abstract] [Full Text] [Related]

  • 6. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [Abstract] [Full Text] [Related]

  • 7. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B, Mühlbacher A, Melchior W.
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [Abstract] [Full Text] [Related]

  • 8. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 9. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 10. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.
    Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM.
    Saudi Med J; 2009 Nov; 30(11):1416-21. PubMed ID: 19882053
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA, Stramer SL, Kuhns MC, Schlauder GG.
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
    Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S.
    Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
    [Abstract] [Full Text] [Related]

  • 18. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A.
    Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
    [Abstract] [Full Text] [Related]

  • 19. The detection of occult HBV infection in patients with HBsAg negative pattern by real-time PCR method.
    Izmirli S, Celik DG, Yuksel P, Saribas S, Aslan M, Ergin S, Bahar H, Sen S, Cakal B, Oner A, Kocazeybek B.
    Transfus Apher Sci; 2012 Dec; 47(3):283-7. PubMed ID: 23021041
    [Abstract] [Full Text] [Related]

  • 20. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
    Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, Atabak S, Amini M, Khadem-Sadegh A, Ramezani A.
    Ther Apher Dial; 2010 Jun; 14(3):349-53. PubMed ID: 20609190
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.